SAMIVIR
Dead / Abandoned — Abandoned — no statement of use filed (as of 27 Mar 2023)
What this means for you
This application is over — abandoned 27 Mar 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90087709
- Mark type
- Stylized text
- Filed
- 02 Aug 2020
- Published for opposition
- 29 Dec 2020
- Abandoned
- 27 Mar 2023
- Attorney of record
- Brian J. Del Buono
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer
Owner
- Neurorx, Inc., Wilmington, DE, US
- Neurorx, Inc., Wilmington, DE, US
Prosecution history
- 27 Mar 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 27 Mar 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 24 Aug 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Aug 2022 — SOU EXTENSION 3 GRANTED
- 22 Aug 2022 — SOU EXTENSION 3 FILED
- 22 Aug 2022 — SOU TEAS EXTENSION RECEIVED
- 15 Apr 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 15 Apr 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 15 Apr 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 24 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Feb 2022 — SOU EXTENSION 2 GRANTED
- 22 Feb 2022 — SOU EXTENSION 2 FILED
- 22 Feb 2022 — SOU TEAS EXTENSION RECEIVED
- 18 Aug 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Aug 2021 — SOU EXTENSION 1 GRANTED